DSCSA 2025: Key Milestones, Challenges, and What Lies Ahead
The year 2024 marked a pivotal moment for the pharmaceutical industry as stakeholders prepared for the Drug Supply Chain Security Act (DSCSA) interoperability deadline on November 27. The legislation, designed to strengthen pharmaceutical products’ security and traceability, posed significant opportunities
Breaking Barriers: Highlights from the Women in Trade Panel at Informa 2024
The Informa Trade & Channel Strategies Conference has long been a key venue for addressing the challenges and opportunities shaping the pharmaceutical trade landscape. Among last year’s highlights was the 2024 Women in Trade panel, where leaders from across the
Unlocking Market Access: Insights from Two Labs on Navigating Pharma’s Complex Commercialization Landscape
On the latest episode of ISPE Boston Area Chapter’s The Future of Pharma podcast, Two Labs’ Kyle Felmet and Riparian LLC’s Jennifer Lospinoso join host Samir Gondalia to discuss how pharmaceutical companies can better navigate market access challenges. As the
Navigating Government Pricing for Cell & Gene Therapies
The wave of FDA-approved cell and gene therapies (CGT) is transforming treatment options for diseases that once had few solutions. As more CGTs move from clinical trial to commercial approval and availability, navigating the complexities of government pricing becomes a